[ACRS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
02-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -16.44%
YoY- -98.39%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 1,528 1,453 1,501 1,659 1,824 1,777 1,580 -2.21%
PBT -20,532 -18,789 -22,804 -21,146 -18,161 -28,754 -13,779 30.55%
Tax -3,862 -1,318 2,003 900 4,800 16,439 -182 670.76%
NP -16,670 -17,471 -22,804 -21,146 -18,161 -28,754 -13,173 17.04%
Tax Rate - - - - - - - -
Total Cost 18,198 18,924 24,305 22,805 19,985 30,531 14,753 15.06%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1,090.97 -1,202.41 -1,519.25 -1,274.62 -995.67 -1,618.12 -833.73 19.69%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.25 -0.28 -0.37 -0.35 -0.34 -0.57 -0.30 -11.47%
EPS Diluted -0.25 -0.28 -0.37 -0.35 -0.34 -0.57 -0.30 -11.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.